Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
The ISO 13485 standard defines the structure of the quality system applied to medical device manufacturers.
This milestone marks the first certification of our site under this internationally recognized standard, awarded by a highly regarded and demanding notified body.
With this certification, valid for three years, it enables our customers to speed up the submission of their applications to notified organization. This reinforces our customers’ confidence in our quality system.
Thanks to our team and partners for making this achievement possible!
HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.
We are excited to share that HTL Biotechnology is present at the AMWC 2025 in Monaco.
On March 10 to 12, 2025, HTL Biotechnology was proud to be present at CIBE (China International Beauty Expo) in Guangzhou, reaffirming our commitment to the dermatology and beauty industries.